Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on August 14, 2003

Stroke. 2003
Published online before print August 14, 2003, doi: 10.1161/01.STR.0000087171.34637.A9
A more recent version of this article appeared on September 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/9/2234    most recent
01.STR.0000087171.34637.A9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerriets, T.
Right arrow Articles by Fisher, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerriets, T.
Right arrow Articles by Fisher, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Stroke
Hazardous Substances DB
*TITANIUM
*TITANIUM DIOXIDE
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction
Right arrow Neuroprotectors

Submitted on April 25, 2003
Accepted on May 19, 2003

Neuroprotective Effects of MK-801 in Different Rat Stroke Models for Permanent Middle Cerebral Artery Occlusion. Adverse Effects of Hypothalamic Damage and Strategies for Its Avoidance

T. Gerriets MD*; E. Stolz MD; M. Walberer DVM; M. Kaps MD; G. Bachmann MD; and M. Fisher MD

From the Department of Radiology, Experimental Neurology Research Group, Kerckhoff Klinik Bad, Nauheim, Germany (T.G., M.W., G.B.); Department of Neurology, University Giessen, Giessen, Germany (T.G., E.S., M.W., M.K.); and Department of Neurology, University of Massachusetts Medical School, Worcester (M.F.).

* To whom correspondence should be addressed. E-mail: Tibo.Gerriets{at}neuro.med.uni-giessen.de.

Background and Purpose--Permanent middle cerebral artery occlusion (MCAO) with the use of the suture technique causes hypothalamic damage with subsequent hyperthermia, which can confound neuroprotective drug studies. In the present study the neuroprotective effects of dizocilpine (MK-801) were compared in different permanent MCAO models with and without hypothalamic damage and hyperthermia.

Methods--Sixty Sprague-Dawley rats were treated with MK-801 or placebo, beginning 15 minutes before MCAO, and assigned to the following groups: suture MCAO (group I), macrosphere MCAO without hypothalamic damage (group II), or macrosphere MCAO with intentionally induced hypothalamic infarction (group III). Body temperature was measured at 3, 6, and 24 hours. Lesion size was determined after 24 hours (2,3,5-triphenyltetrazolium chloride staining).

Results--Hypothalamic damage was present in animals in group I and was intentionally induced in group III with the use of a modified macrosphere MCAO technique. Body temperature was significantly increased 3, 6, and 24 hours after MCAO in these 2 groups of animals. Hypothalamic damage and subsequent hyperthermia could be avoided effectively by limiting the number of macrospheres (group II). MK-801 provided a highly significant neuroprotective effect in group II but not in groups I and III.

Conclusions--Hypothalamic damage with subsequent hyperthermia masked the neuroprotective effect of MK-801. This side effect can be avoided by using the macrosphere MCAO technique with a limited number of spheres. This model therefore may be more appropriate to study the effects of neuroprotective drugs in permanent focal cerebral ischemia than the suture method.


Key words: animal models • cerebral infarction • MK-801 • neuroprotection




This article has been cited by other articles:


Home page
StrokeHome page
K. Tsuda
Role of Hyperglycemia and Glutamate Receptors in Ischemic Injury in Acute Cerebral Infarction
Stroke, September 1, 2006; 37(9): 2199 - 2199.
[Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
H. P. Grocott, H. M. Homi, and F. Puskas
Cognitive Dysfunction After Cardiac Surgery: Revisiting Etiology
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2005; 9(2): 123 - 129.
[Abstract] [PDF]


Home page
StrokeHome page
T. Gerriets, E. Stolz, M. Walberer, C. Muller, C. Rottger, A. Kluge, M. Kaps, M. Fisher, and G. Bachmann
Complications and Pitfalls in Rat Stroke Models for Middle Cerebral Artery Occlusion: A Comparison Between the Suture and the Macrosphere Model Using Magnetic Resonance Angiography
Stroke, October 1, 2004; 35(10): 2372 - 2377.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Tsuda, T. Gerriets, E. Stolz, M. Walberer, M. Kaps, G. Bachmann, and M. Fisher
Neuroprotective Effects of MK-801 and Catecholamine Release in the Central Nervous System * Response: Neuroprotective Effects of MK-801 and Catecholamine Release in the Central Nervous System
Stroke, May 1, 2004; 35(5): e96 - e96.
[Full Text] [PDF]